The Journal of Translational Medicine Impact Factor：What You Should Know?

The Journal of Translational Medicine has an Impact Factor of 7.5 (2024).

Based on the official 2024 metrics published by BioMed Central (Springer Nature), this places Journal of Translational Medicine among the leading Q1 journals in fields like experimental medicine and translational biomedicine. Its outstanding ​5-year Impact Factor of 7.0, strong SCImago Journal Rank (SJR) of 1.997, and high h‑index of 153 reflect its sustained influence and citation appeal.

What is The Journal of Translational Medicine?

The Journal of Translational Medicine (often called ​BMC Journal of Translational Medicine​) has been part of Springer’s BioMed Central since 2003. It’s a fully open-access, peer-reviewed journal (ISSN: 1479‑5876), concentrating on research derived directly from ​human experimentation​, such as early clinical trials and biomarker studies, with the goal of bridging basic lab findings and real-life clinical applications. It publishes continuously—no fixed volume or issue numbers—and brings studies online immediately after acceptance.

What Does the Journal of Translational Medicine Cover?

You'd expect the usual suspects — oncology, neurology, immunology — and yes, those are there. But JTM also embraces:

• Personalized medicine
• Gene therapy and molecular diagnostics
• Immunotherapy and vaccine development
• Biomarker discovery
• Digital health and AI in medicine

Basically, if your research can go from bench to bedside — and maybe even change how we treat people globally — it probably belongs here.

The journal also loves multidisciplinary work. So if you're the oddball working with both CRISPR and wearable biosensors, don't worry. You're in good company.

What’s the Mission of Translational Medicine ?

According to its editorial philosophy, JTM is on a mission to accelerate clinical applications of research. But not just any research — it prioritizes studies with real-world relevance. Think beyond statistical significance. Think ​patient impact​.

And here's the thing: JTM isn’t shy about shaking things up. It actively encourages innovative methodologies, non-traditional study designs, and cross-disciplinary work. If your research challenges old models, this might just be your platform.

Journal of Translational Medicine Abbreviation & Indexing

The official ISO‑4 abbreviation is ​J. Transl. Med. ​—commonly used in citations and indexing systems like PubMed and Web of Science.

• ​ISSN​: 1479-5876
• ​Indexed in​: PubMed, Scopus, Web of Science, Google Scholar, and more.

Other key figures:

• ​SCImago Journal Rank (SJR 2024)​: ​1.997​, placing Journal of Translational Medicine firmly in Q1 of both Medicine and Biochemistry & Molecular Biology categories.
• ​h‑index​: ​153​, reflecting high citation impact and consistent output over time.

What's the Journal of Translational Medicine Acceptance Rate？

BioMed Central does ​not formally publish acceptance rates​, but user reports from platforms like LetPub indicate:

• ​Estimated acceptance rate​: around ​~50%​, though not officially verified.
• The [peer-review policy] involves at least two expert reviewers evaluating scientific soundness, clarity, and originality, before editors make a decision.
• ​Median time to first decision​: typically around 11 days.

These timelines stem from user-submitted experiences and may not represent every submission.

What Are the Author Guidelines and Submission Process?

Key submission points from the journal’s official guidance:

• Manuscript via Editorial Manager system.
• Prepare the main document: ~4,000–5,000 words (single column, 10 pt), with structured sections: abstract, methods, ethics, data availability, Funding, Authors' contributions, and Declarations including competing interests and acknowledgments.
• Data availability section is mandatory, encouraging linking to repositories or including supporting files.
• Authors retain copyright and sign a Creative Commons license (e.g. CC BY) to allow reuse, while BMC retains publishing rights.
• This journal endorses ICMJE recommendations regarding authorship and ethical standards.

Turn Search Into Insight with PubMed.ai Research Reports

Tired of sifting through endless papers to find what's relevant? With **PubMed.ai Research Reports**​, you can generate structured, AI-powered research summaries in just one click.
Read More:

• Computers in Biology and Medicine
• NPJ Precision Oncology Impact Factor 2024
• Cell Death and Disease Impact Factor: What Researchers Need to Know

FAQs about the Journal of Translational Medicine

What is the Journal of Translational Medicine abbreviation?

The official abbreviation is J. Transl. Med.

Is the Journal of Translational Medicine indexed in PubMed and Scopus?

Yes, it is fully indexed in ​PubMed​, ​Scopus​, ​Web of Science​, and other major databases.

What types of articles does the Journal of Translational Medicine publish?

JTM accepts original research, reviews, short reports, methodology papers, and editorials. It prioritizes work with a clear translational pathway and real-world clinical relevance.

Disclaimer:
This AI-assisted content is intended for academic reference and informational purposes only. While every effort is made to ensure accuracy, journal metrics (such as Impact Factor and APC fees) are subject to official annual updates. Users should verify the latest data via official platforms before making submission or citation decisions. This content does not constitute medical advice, diagnosis, or treatment. Always consult qualified healthcare professionals regarding any medical condition or treatment decisions. All risks arising from reliance on this content are borne by the user, and the publisher assumes no responsibility for any decisions or actions taken.